{"id":2247,"date":"2025-05-23T09:00:39","date_gmt":"2025-05-23T00:00:39","guid":{"rendered":"https:\/\/prismbiolab.com\/?post_type=news&#038;p=2247"},"modified":"2025-05-28T02:59:17","modified_gmt":"2025-05-27T17:59:17","slug":"eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting","status":"publish","type":"news","link":"https:\/\/prismbiolab.com\/ja\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/","title":{"rendered":"PRISM BioLab\u3068\u30a8\u30fc\u30b6\u30a4\u304c\u5171\u540c\u5275\u51fa\u3057\u305fE7386\u3001\u30a8\u30fc\u30b6\u30a4\u304c\u7c73\u56fd\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u6b21\u7dcf\u4f1a\u306b\u3066\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3092\u767a\u8868"},"content":{"rendered":"<p data-renderer-start-pos=\"349\"><span class=\"fabric-text-color-mark\" data-renderer-mark=\"true\" data-text-custom-color=\"#172b4d\">\u682a\u5f0f\u4f1a\u793e PRISM BioLab\u306f \u30012025 \u5e74 5\u6708 30 \u65e5\u304b\u30896 \u6708 3 \u65e5\u307e\u3067\u7c73\u56fd\u30fb\u30b7\u30ab\u30b4\u306b\u304a\u3044\u3066\u958b\u50ac\u3055\u308c\u308b\u7c73\u56fd\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\uff08American Society of Clinical Oncology\uff1aASCO\uff09\u5e74\u6b21\u7dcf\u4f1a\uff082025 ASCO Annual Meeting\uff09\u306b\u304a\u3044\u3066\u3001PRISM BioLab\u3068\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u306b\u3088\u308a\u5171\u540c\u5275\u51fa\u3055\u308c\u305fE7386\u3068\u30ec\u30f3\u30d0\u30c1\u30cb\u30d6\u30e1\u30b7\u30eb\u9178\u5869\u3068\u306e\u4f75\u7528\u8a66\u9a13\u306e\u7d50\u679c\u304c\u30a8\u30fc\u30b6\u30a4\u306b\u3088\u308a\u767a\u8868\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3042\u308a\u3001\u672c\u65e5\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\uff08\u7814\u7a76\u6982\u8981\uff09\u304c\u958b\u793a\u3055\u308c\u307e\u3057\u305f\u306e\u3067\u3001\u304a\u77e5\u3089\u305b\u3044\u305f\u3057\u307e\u3059\u3002<\/span><\/p>\n<p data-renderer-start-pos=\"917\"><a href=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2025\/05\/CLEAN_JPN_ASCO2025.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"fabric-text-color-mark\" data-renderer-mark=\"true\" data-text-custom-color=\"#172b4d\">\u8a73\u7d30\u306f\u3053\u3061\u3089<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>TOKYO, Japan, 23 May 2025: &#8212; PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the analysis of a combination study of E7386, created through collaboration research with Eisai Co., Ltd. , and Lenvatinib mesylate (\u201clenvatinib\u201d) will be presented by [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"news-category":[8],"class_list":["post-2247","news","type-news","status-publish","hentry","news-category-news","post"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - PRISM BioLab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prismbiolab.com\/ja\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - PRISM BioLab\" \/>\n<meta property=\"og:description\" content=\"TOKYO, Japan, 23 May 2025: &#8212; PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the analysis of a combination study of E7386, created through collaboration research with Eisai Co., Ltd. , and Lenvatinib mesylate (\u201clenvatinib\u201d) will be presented by [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prismbiolab.com\/ja\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"PRISM BioLab\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T17:59:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1122\" \/>\n\t<meta property=\"og:image:height\" content=\"1097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\\\/\",\"name\":\"Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - PRISM BioLab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\"},\"datePublished\":\"2025-05-23T00:00:39+00:00\",\"dateModified\":\"2025-05-27T17:59:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prismbiolab.com\\\/news\\\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"name\":\"PRISM BioLab\",\"description\":\"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges\",\"publisher\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prismbiolab.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\",\"name\":\"PRISM BioLab\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"contentUrl\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"width\":300,\"height\":367,\"caption\":\"PRISM BioLab\"},\"image\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRISM BioLab\u3068\u30a8\u30fc\u30b6\u30a4\u304c\u5171\u540c\u5275\u51fa\u3057\u305fE7386\u3001\u30a8\u30fc\u30b6\u30a4\u304c\u7c73\u56fd\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u6b21\u7dcf\u4f1a\u306b\u3066\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3092\u767a\u8868 - PRISM BioLab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prismbiolab.com\/ja\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/","og_locale":"ja_JP","og_type":"article","og_title":"Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - PRISM BioLab","og_description":"TOKYO, Japan, 23 May 2025: &#8212; PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the analysis of a combination study of E7386, created through collaboration research with Eisai Co., Ltd. , and Lenvatinib mesylate (\u201clenvatinib\u201d) will be presented by [&hellip;]","og_url":"https:\/\/prismbiolab.com\/ja\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/","og_site_name":"PRISM BioLab","article_modified_time":"2025-05-27T17:59:17+00:00","og_image":[{"width":1122,"height":1097,"url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/prismbiolab.com\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/","url":"https:\/\/prismbiolab.com\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/","name":"PRISM BioLab\u3068\u30a8\u30fc\u30b6\u30a4\u304c\u5171\u540c\u5275\u51fa\u3057\u305fE7386\u3001\u30a8\u30fc\u30b6\u30a4\u304c\u7c73\u56fd\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u6b21\u7dcf\u4f1a\u306b\u3066\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3092\u767a\u8868 - PRISM BioLab","isPartOf":{"@id":"https:\/\/prismbiolab.com\/#website"},"datePublished":"2025-05-23T00:00:39+00:00","dateModified":"2025-05-27T17:59:17+00:00","breadcrumb":{"@id":"https:\/\/prismbiolab.com\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prismbiolab.com\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prismbiolab.com\/news\/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prismbiolab.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/prismbiolab.com\/news\/"},{"@type":"ListItem","position":3,"name":"Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/prismbiolab.com\/#website","url":"https:\/\/prismbiolab.com\/","name":"PRISM BioLab","description":"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges","publisher":{"@id":"https:\/\/prismbiolab.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prismbiolab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/prismbiolab.com\/#organization","name":"PRISM BioLab","url":"https:\/\/prismbiolab.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/","url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","contentUrl":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","width":300,"height":367,"caption":"PRISM BioLab"},"image":{"@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/2247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/comments?post=2247"}],"version-history":[{"count":2,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/2247\/revisions"}],"predecessor-version":[{"id":2251,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/2247\/revisions\/2251"}],"wp:attachment":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/media?parent=2247"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/tags?post=2247"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news-category?post=2247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}